Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Clinical trial NCT03894046 · COMPLETED

Trial details

NCT number: NCT03894046
Sponsor: Entasis Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acinetobacter Baumannii-calcoaceticus Complex Hospital-acquired Bacterial Pneumonia Ventilator-associated Bacterial Pneumonia Bacteremia Colistin Resistant ABC

Start date: 2019-09-05
Primary completion: 2021-07-26
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.